This pilot study will evaluate the feasibility of pain-guided activity modification during rehabilitation for patellar tendinopathy. The information provided will be utilized to conduct a larger randomized clinical trial to determine if there is a difference in recovery from patellar tendinopathy during rehabilitation between individuals that use pain-guided activity modification and those that halt all painful activities. Recovery from patellar tendinopathy will be assessed using pain ratings, tendon-specific outcome measures, tendon structure, tendon mechanical properties, and muscle function.
Age range
16 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Willingness to Participate
Timeframe: Percentage over initial year of study recruitment
Drop Out Rate
Timeframe: Percentage over initial year of study recruitment
Symptoms
Timeframe: Change over time with evaluations at baseline, 6-weeks, and 12-weeks
Tendon Structure
Timeframe: Change over time with evaluations at baseline, 6-weeks, and 12-weeks
Continuous Shear Wave Elastography (cSWE) to measure tendon mechanical properties
Timeframe: Change over time with evaluations at baseline, 6-weeks, and 12-weeks
Muscle-tendon function
Timeframe: Change over time with evaluations at baseline, 6-weeks, and 12-weeks